The sequence gamma-(312-324) is a fibrin-specific epitope

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Fibrin plays a crucial role in hemostasis and thrombosis.
• Fibrinogen is the precursor to fibrin, and their conversion is a key step in clot formation.
• Tissue-type plasminogen activator (t-PA) activates plasminogen to plasmin, initiating fibrinolysis.

Purpose of the Study:

• To investigate the molecular mechanisms by which fibrin enhances plasminogen activation by t-PA.
• To identify specific sites within the fibrin molecule responsible for this rate-enhancing effect.
• To characterize the accessibility of these sites during the transition from fibrinogen to fibrin.

Main Methods:

• Utilized monoclonal antibodies to probe specific peptide sequences within fibrinogen and fibrin.
• Synthesized peptide fragments corresponding to potential fibrin-binding sites.
• Performed binding assays to assess antibody reactivity with fibrinogen and fibrin.
• Investigated the effect of fibrin formation on the accessibility of specific fibrin epitopes.

Main Results:

• Fibrin significantly accelerates plasminogen activation catalyzed by t-PA, more so than fibrinogen.
• Two key sites in fibrin, A alpha-(148-160) and a region within the gamma-chain (FCB-5), contribute to this enhancement.
• A monoclonal antibody against A alpha-(148-160) binds fibrin but not fibrinogen, indicating its exposure upon fibrin formation.
• A novel monoclonal antibody against gamma-(312-324) (part of FCB-5) also demonstrates fibrin-specificity, binding fibrin but not fibrinogen.

Conclusions:

• The fibrin-specific antibody against gamma-(312-324) confirms that this peptide region is hidden in fibrinogen and becomes accessible after fibrin formation.
• These exposed sites on fibrin contribute to the enhanced activation of plasminogen, influencing the fibrinolytic system.
• The findings elucidate the structural basis for fibrin's pro-fibrinolytic role, mediated by specific molecular interactions.